Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Journal articles

Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V; Eurocord, Cord Blood Committee of Cellular Therapy and Immunobiology Working Party of the EBMT, Federal University of Parana, Duke University Medical Center and Inborn Errors Working Party of the EBMT , 2017, 'A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.', Haematologica, 102, pp. 1112 - 1119, http://dx.doi.org/10.3324/haematol.2016.158808

Harris AC; Boelens JJ; Ahn KW; Fei M; Abraham A; Artz A; Dvorak CC; Frangoul H; Freytes CO; Gale RP; Hong S; Lazarus HM; Mineishi S; Nishihori T; O'Brien T; Williams KM; Pasquini MC; Levine JE, 2016, 'Comparison of Outcomes for Myeloablative Conditioning Regimens Combining Busulfan with Either Cyclophosphamide or Fludarabine in Children', Blood, 128, pp. 664, http://dx.doi.org/10.1182/blood.v128.22.664.664

Bresters D; Lawitschka A; Cugno C; Pötschger U; Dalissier A; Michel G; Vettenranta K; Sundin M; Al-Seraihy A; Faraci M; Sedlacek P; Versluys AB; Jenkins A; Lutz P; Gibson B; Leiper A; Diaz MA; Shaw PJ; Skinner R; O'Brien TA; Salooja N; Bader P; Peters C, 2016, 'Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters', Bone Marrow Transplantation, 51, pp. 1482 - 1489, http://dx.doi.org/10.1038/bmt.2016.139

Westbrook JI; Li L; Raban MZ; Baysari MT; Mumford V; Prgomet M; Georgiou A; Kim T; Lake R; McCullagh C; Dalla-Pozza L; Karnon J; O'Brien TA; Ambler G; Day R; Cowell CT; Gazarian M; Worthington R; Lehmann CU; White L; Barbaric D; Gardo A; Kelly M; Kennedy P, 2016, 'Stepped-wedge cluster randomised controlled trial to assess the effectiveness of an electronic medication management system to reduce medication errors, adverse drug events and average length of stay at two paediatric hospitals: A study protocol', BMJ Open, 6, pp. e011811, http://dx.doi.org/10.1136/bmjopen-2016-011811

Nelson AS; Marsh RA; Myers KC; Davies SM; Jodele S; O'Brien TA; Mehta PA, 2016, 'A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation', Biology of Blood and Marrow Transplantation, 22, pp. 884 - 888, http://dx.doi.org/10.1016/j.bbmt.2016.01.026

Vajdic CM; Mayson E; Dodds AJ; O'Brien T; Wilcox L; Nivison-Smith I; Le Marsney R; Daniels B; Ashton LJ; Tan J; Bilmon I; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2016, 'Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study', Biology of Blood and Marrow Transplantation, 22, pp. 949 - 956, http://dx.doi.org/10.1016/j.bbmt.2016.01.027

Michel G; Cunha R; Ruggeri A; O'Brien TA; Bittencourt H; Dalle JH; Locatelli F; Iori AP; Mauad M; Oudin C; Giannotti F; Volt F; Gluckman E; Bader P; Rocha V, 2016, 'Unrelated cord blood transplantation for childhood acute myelogenous leukemia: The influence of cytogenetic risk group stratification', Leukemia, 30, pp. 1180 - 1183, http://dx.doi.org/10.1038/leu.2015.243

Chapman L; Johnston K; Maurice L; O'Brien T, 2016, 'Developing a Hematopoietic Progenitor Cell Transplant (HPCT) Timeline for Educating Nursing Staff and Families', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, pp. S463 - S463, http://dx.doi.org/10.1016/j.bbmt.2015.11.1060

Koyyalamudi SR; Kuzhiumparambil U; Nath CE; Byrne JA; Fraser CJ; O'brien TA; Earl JW; Shaw PJ, 2016, 'Development and validation of a high pressure liquid Chromatography-UV method for the determination of treosulfan and its epoxy metabolites in human plasma and its application in pharmacokinetic studies', Journal of Chromatographic Science, 54, pp. 326 - 333, http://dx.doi.org/10.1093/chromsci/bmv145

Vrooman L; Millard H; Brazauskas R; Majhail NS; Battiwallas M; Flowers MED; Savani BN; Akpek G; Aljurf MD; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Dandoy CE; Gale RP; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; O'Brien T; Olsson R; Reddy V; Willert JR; Ringden O; Schears RM; Seo S; Steinberg A; Yu LC; Shaw BE; Duncan C, 2016, 'Survival and Late Effects of Children Undergoing Myeloablative Allogeneic HCT at Less Than Three Years of Age: A Report from the Center for International Blood and Marrow Transplant Research', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 22, pp. S28 - S29, http://dx.doi.org/10.1016/j.bbmt.2015.11.311

Koenecke C; Heim D; van Biezen A; Heuser M; Aljurf M; Kyrcz-Krzemien S; Volin L; de Souza CA; Gedde-Dahl T; Sengeloev H; Schanz U; Komarnicki M; Arroyo CH; Tholouli E; Gluckman E; Esquirol A; Yakoub-Agha I; Gürman G; Olavarria E; Kröger N, 2016, 'Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party', Bone Marrow Transplantation, 51, pp. 1259 - 1261, http://dx.doi.org/10.1038/bmt.2016.97

Dolnikov A; Yang S; Shen S; Xu N; Chaudhry K; Nordon R; O'Brien T, 2016, 'Prolonging CART Cell Persistence Using Conditioning with 5-Azacytidine', Cytotherapy, 18, pp. S98 - S98, http://dx.doi.org/10.1016/j.jcyt.2016.03.201

Green D; O'Brien T, 2016, 'Restoration to normal physiology without the use of excessive fluids', British Journal of Anaesthesia, 117, pp. 264 - 266, http://dx.doi.org/10.1093/bja/aew203

Shen S; Xu N; Yang S; O'Brien T; Dolnikov A, 2016, 'Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer', Cytotherapy, 18, pp. S101 - S101, http://dx.doi.org/10.1016/j.jcyt.2016.03.211

Shen S; Dolnikov A; O'Brien T, 2016, 'Use of HDACi and PD-1/PD-L1 Blockade to Enhance Cytolytic Activity of Ex Vivo Expanded NK Cells Against Neuroblastoma', Cytotherapy, 18, pp. S101 - S101, http://dx.doi.org/10.1016/j.jcyt.2016.03.212

Page KM; Labopin M; Ruggeri A; Michel G; de Heredia CD; O'Brien T; Picardi A; Ayas M; Bittencourt H; Vora AJ; Volt F; Gluckman E; Bader P; Kurtzberg J; Rocha V, 2015, 'Impact of GvHD and Other Patient-, Disease-, Donor and Transplantation-Related Factors on 5 Year Relapse after Unrelated Cord Blood Transplantation for Children with Acute Lymphoblastic Leukemia in Remission', Blood, 126, pp. 4384, http://dx.doi.org/10.1182/blood.v126.23.4384.4384

Fioredda F; Korthof ET; Iacobelli S; Knol C; Veelken JH; Veys P; Yoshimi A; Mellegren K; Fagioli F; Zecca M; Maschan A; O'Brien T; Angel Diaz M; Smith O; Socie G; Josue DLF; Or R; Dufour C, 2015, 'Outcome of BONE Marrow Transplantation in Congenital Diskeratosis: Preliminary DATA from the European Group for BONE Marrow Transplantation (EBMT)', BLOOD, 126, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000368020105189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ponce DM; Eapen M; Sparapani R; O'Brien TA; Chan KW; Chen J; Craddock J; Schultz KR; Wagner JE; Perales MA; Barker JN, 2015, 'In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children', Biology of Blood and Marrow Transplantation, 21, pp. 2173 - 2179, http://dx.doi.org/10.1016/j.bbmt.2015.08.022

Orchard PJ; Fasth AL; Le Rademacher JL; He W; Boelens JJ; Horwitz EM; Al-Seraihy A; Ayas M; Bonfim CM; Boulad F; Lund T; Buchbinder DK; Kapoor N; OBrien TA; Perez MAD; Veys PA; Eapen M, 2015, 'Hematopoietic stem cell transplantation for infantile osteopetrosis', Blood, 126, pp. 270 - 276, http://dx.doi.org/10.1182/blood-2015-01-625541

Walsh K; Zwi K; Woolfenden S; Shlonsky A, 2015, 'School-based education programmes for the prevention of child sexual abuse', Cochrane Database of Systematic Reviews, 2015, http://dx.doi.org/10.1002/14651858.CD004380.pub3

Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A, 2015, 'Small-molecule inhibitor of glycogen synthase kinase 3β 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice', Stem Cells and Development, 24, pp. 724 - 736, http://dx.doi.org/10.1089/scd.2014.0230

Wright FA; Bebawy M; O'Brien TA, 2015, 'An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantation', Future Oncology, 11, pp. 833 - 851, http://dx.doi.org/10.2217/fon.14.307

Nelson AS; Ashton LJ; Vajdic CM; Le Marsney RE; Daniels B; Nivison-Smith I; Wilcox L; Dodds AJ; O'Brien TA; Moa A, 2015, 'Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy', Leukemia, 29, pp. 441 - 447, http://dx.doi.org/10.1038/leu.2014.203

Nelson AS; Davies SM; Myers KC; Marsh RA; Jodele S; Mount L; O'Brien TA; Mehta PA, 2015, 'Improved Outcomes in Patients with Dyskeratosis Congenita (DC) Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT) Using Reduced Intensity Conditioning', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21, pp. S233 - S234, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000348633000319&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA, 2015, 'Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia', British Journal of Haematology, 168, pp. 395 - 404, http://dx.doi.org/10.1111/bjh.13142

Bartlett A; Goeman E; Vedi A; Mostaghim M; Trahair T; O’Brien TA; Palasanthiran P; McMullan B, 2015, 'A pilot study of a computerized decision support system to detect invasive fungal infection in pediatric hematology/oncology patients', Infection Control and Hospital Epidemiology, 36, pp. 1313 - 1317, http://dx.doi.org/10.1017/ice.2015.179

Dolnikov A; Shen S; Klamer G; Joshi S; Xu N; Yang L; Micklethwaite K; O'Brien TA, 2015, 'Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia', Experimental Hematology, 43, pp. 1001 - 1014.e5, http://dx.doi.org/10.1016/j.exphem.2015.08.006

Gray PE; O'Brien TA; Wagle M; Tangye SG; Palendira U; Roscioli T; Choo S; Sutton R; Ziegler JB; Frith K, 2015, 'Cerebral Vasculitis in X-linked Lymphoproliferative Disease Cured by Matched Unrelated Cord Blood Transplant.', Journal of clinical immunology, 35, pp. 604 - 609, http://dx.doi.org/10.1007/s10875-015-0194-9

Locatelli F; Labopin M; Michel G; Handgretinger R; de Heredia CD; Bertaina A; Mouhab A; O’Brien T; Cornish JM; Dalle J-H; Caniglia M; Zecca M; Acma A; Kenzey C; Giannotti F; Peters C; Rocha V; Bader P; Gluckman E; Ruggeri A, 2014, 'Comparison Between Related T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (TCD-Haplo) and Umbilical Cord Blood Transplantation (UCBT) in Pediatric Patients with Acute Leukemia, a Eurocord, PDWP-EBMT Study', Blood, 124, pp. 1215, http://dx.doi.org/10.1182/blood.v124.21.1215.1215

Jordens CFC; Kerridge IH; Stewart CL; O'Brien TA; Samuel G; Porter M; O'Connor MAC; Nassar N, 2014, 'Knowledge, Beliefs, and Decisions of Pregnant Australian Women Concerning Donation and Storage of Umbilical Cord Blood: A Population-Based Survey', Birth, 41, pp. 360 - 366, http://dx.doi.org/10.1111/birt.12121

Ruggeri A; Labopin M; Sormani MP; Sanz G; Sanz J; Volt F; Michel G; Locatelli F; De Heredia CD; O'Brien T; Arcese W; Iori AP; Querol S; Kogler G; Lecchi L; Pouthier F; Garnier F; Navarrete C; Baudoux E; Fernandes J; Kenzey C; Eapen M; Gluckman E; Rocha V; Saccardi R, 2014, 'Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen', Haematologica, 99, pp. 1509 - 1515, http://dx.doi.org/10.3324/haematol.2014.109280

Bilmon IA; Ashton LJ; Le Marsney RE; Dodds AJ; O'brien TA; Wilcox L; Nivison-Smith I; Daniels B; Vajdic CM; Dodds A; Tan J; Aarons D; Tran S; Gibson J; Johnston A; Greenwood M; Forbes M; Hertzberg M; Huang G; Spencer A; Muirhead J; Szer J; Mason K; Lewis I; To C; Durrant S; Western R; Cannell P; Buffery S; Oswald C; Nelson A; Shaw P; Pearson L; Tiedemann K; Scoyne M; Fraser C; Seljak J; Cole C; Rowland K; Gough H; Tapp H; Green N; Moa A; McRae J; Jenkins M; Hicks J; Chaplin K, 2014, 'Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: A population-based cohort study', Bone Marrow Transplantation, 49, pp. 691 - 698, http://dx.doi.org/10.1038/bmt.2014.13

Ashton LJ; Le Marsney RE; Dodds AJ; Nivison-Smith I; Wilcox L; O'Brien TA; Vajdic CM, 2014, 'A Population-Based Cohort Study of Late Mortality in Adult Autologous Hematopoietic Stem Cell Transplant Recipients in Australia', Biology of Blood and Marrow Transplantation, 20, pp. 937 - 945, http://dx.doi.org/10.1016/j.bbmt.2014.03.006

Cunha R; Loiseau P; Ruggeri A; Sanz G; Michel G; Iori AP; Socié G; Arcese W; Picardi A; Dias De Heredia C; Rio B; Locatelli F; O'Brien TA; Yakoub-Agha I; Diaz MA; Milpied N; Bittencourt H; Souza MP; Aljurf M; Charron D; Boudjedir K; Labopin M; Gluckman E; Rocha V, 2014, 'Erratum: Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: A retrospective Eurocord-EBMT analysis (Bone Marrow Transplantation (2014) 49 (864))', Bone Marrow Transplantation, 49, pp. 864, http://dx.doi.org/10.1038/bmt.2014.82

Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA, 2014, 'GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells', Cell Proliferation, 47, pp. 113 - 123, http://dx.doi.org/10.1111/cpr.12092

Törlén J; Ringdén O; Le Rademacher J; Batiwalla M; Chen J; Erkers T; Ho V; Kebriaei P; Keever-Taylor C; Kindwall-Keller T; Lazarus HM; Laughlin MJ; Lill M; O'Brien T; Perales MA; Rocha V; Savani BN; Szwajcer D; Valcarcel D; Eapen M, 2014, 'Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome', Biology of Blood and Marrow Transplantation, 20, pp. 1418 - 1425, http://dx.doi.org/10.1016/j.bbmt.2014.05.021

Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Perez MAD; Fraser C; Gross TG; Horan JT; Kennedy-Nasser AA; Kitko C; Kurtzberg J; Lehmann L; O'Brien T; Pulsipher MA; Smith FO; Zhang MJ; Eapen M; Carpenter PA, 2014, 'Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome', Pediatric Blood and Cancer, 61, pp. 1126 - 1128, http://dx.doi.org/10.1002/pbc.24918

Cunha R; Ruggeri A; Boudjedir K; Gluckman E; Rocha V; Loiseau P; Charron D; Sanz G; Michel G; Paolaiori A; Socié G; Arcese W; Picardi A; Dias De Heredia C; Rio B; Locatelli F; O'Brien TA; Yakoub-Agha I; Angel Diaz M; Milpied N; Bittencourt H; Pedro Souza M; Aljurf M; Labopin M, 2014, 'Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: A retrospective Eurocord-EBMT analysis', Bone Marrow Transplantation, 49, pp. 24 - 29, http://dx.doi.org/10.1038/bmt.2013.120

Hol J; Ruggeri A; Rocha VG; Michel G; Ayas M; O'Brien T; Krivan G; Bordon V; Schots R; Rovelli A; Elorza I; Moraleda J; Shaw PJ; Renard M; Sykora K-W; Or R; Zuckerman T; Abecasis M; Bredius R; Yesilipek MA; Diaz MA; Gennery A; Gluckman E; Boelens J-J, 2014, 'Outcomes of Allogeneic Cord Blood Transplantation for Leukodystrophies; A Joint Study of Eurocord and "Inborn Errors WP-EBMT"', Transplantation and Cellular Therapy, 20, pp. s86 - s87, http://dx.doi.org/10.1016/j.bbmt.2013.12.109

Thörlén J; Ringdén O; Le Rademacher J; Battiwalla M; Chen J; Ho VT; Kebriaei P; Keever-Taylor CA; Kindwall-Keller TL; Lazarus HM; Laughlin MJ; Lill M; O'Brien TA; Perales MA; Rocha V; Savani BN; Szwajcer D; Valcarcel D; Eapen M, 2013, 'Low CD34 Cell Dose Is Associated With Higher Non-Relapse and Overall Mortality After Reduced Intensity Conditioning Hematopoietic Cell Transplantation For Acute Myeloid Leukemia and Myelodysplastic Syndrome', Blood, 122, pp. 3342, http://dx.doi.org/10.1182/blood.v122.21.3342.3342

Janna H; Ruggeri A; Rocha V; Michel G; Ayas M; O'Brien T; Krivan G; Victoria B; Schots R; Attilio R; Izaskun E; Moraleda JM; Shaw PJ; Renard M; Sykora K-W; Or R; Zuckerman T; Abecasis M; Robbert B; Yesilipek MA; Diaz MA; Andy G; Gluckman E; Boelens JJ, 2013, 'Outcomes Of Allogeneic Cord Blood Transplantation For Leukodystrophies; A Joint Study of Eurocord and “Inborn Errors WP-EBMT”', Blood, 122, pp. 2101, http://dx.doi.org/10.1182/blood.v122.21.2101.2101

Ruggeri A; Volt F; Michel G; de Heredia CD; Abecasis M; Zecca M; Locatelli F; Vora AJ; Yakouben K; O'Brien T; Dini G; Cornish J; Gluckman E; Peters C; Rocha V; Dalle J-H, 2013, 'Unrelated Cord Blood Transplantation For Infant Acute Leukemia Diagnosed Within 1 Year Of Age: Outcomes and Risk Factor Analysis On Behalf Of Eurocord and PDWP-EBMT', Blood, 122, pp. 160, http://dx.doi.org/10.1182/blood.v122.21.160.160

Hanchard N; Goodchild L; Thompson J; O'Brien T; Richardson C; Watson H, 2013, 'Evaluation of clinical guidelines for contracted (frozen) shoulder 12-18 months after publication', INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION, 20, pp. 543 - 549, http://dx.doi.org/10.12968/ijtr.2013.20.11.543

Locatelli F; Crotta A; Ruggeri A; Eapen M; Wagner JE; MacMillan ML; Zecca M; Kurtzberg J; Bonfim C; Vora A; De Heredia CD; Teague L; Stein J; O'Brien TA; Bittencourt H; Madureira A; Strahm B; Peters C; Niemeyer C; Gluckman E; Rocha V, 2013, 'Analysis of risk factors influencing outcomes after cord blood transplantation in children with juvenile myelomonocytic leukemia: A EUROCORD, EBMT, EWOG-MDS,CIBMTR study', Blood, 122, pp. 2135 - 2141, http://dx.doi.org/10.1182/blood-2013-03-491589

Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw PJ; Teague L; Fraser CJ; Carter TL; Tapp H; Alvaro F; O'Brien TA, 2013, 'Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: A report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry', Pediatric Transplantation, 17, pp. 582 - 588, http://dx.doi.org/10.1111/petr.12109

Hitzler JK; He W; Doyle J; Cairo M; Camitta BM; Chan KW; Diaz Perez MA; Fraser C; Gross TG; Horan JT; Kennedy-Nasser AA; Kitko C; Kurtzberg J; Lehmann L; O'Brien T; Pulsipher MA; Smith FO; Zhang MJ; Eapen M; Carpenter PA, 2013, 'Outcome of transplantation for acute myelogenous leukemia in children with down syndrome', Biology of Blood and Marrow Transplantation, 19, pp. 893 - 897, http://dx.doi.org/10.1016/j.bbmt.2013.02.017

Shen S; Xu N; Klamer G; O'Brien TA; Dolnikov A, 2013, 'NOVEL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS USING GENETICALLY MODIFIED T CELL PRECURSORS', CYTOTHERAPY, 15, pp. S54 - S54, http://dx.doi.org/10.1016/j.jcyt.2013.01.211

Mitchell R; Nivison-Smith I; Anazodo A; Tiedemann K; Shaw P; Teague L; Fraser C; Carter T; Tapp H; Alvaro F; O'Brien TA, 2013, 'Outcomes of Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency: A Report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry', Biology of Blood and Marrow Transplantation, 19, pp. 338 - 343, http://dx.doi.org/10.1016/j.bbmt.2012.11.619

Chapman L; Senner AM; Wright FA; Maurice L; Lenthen K; O'Dwyer C; Maguire F; O'Brien T, 2013, 'Aboriginal Australians - Unique Issues in Hematopoietic Stem Cell Transplant', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19, pp. S357 - S357, http://dx.doi.org/10.1016/j.bbmt.2012.11.563

Wright FA; Davis EL; Oswald C; O'Brien T, 2013, 'Upfront Calcineurin Inhibitor Dose Reduction of 40% in Pediatric Haematopoietic Stem Cell Transplant Does Not Result in Increased Graft Versus Host Disease in Patients Receiving Voriconazole Maintenance Therapy', BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 19, pp. S380 - S380, http://dx.doi.org/10.1016/j.bbmt.2012.11.618


Back to profile page